Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Theravance Biopharma Inc (TBPH)
USD16.98
+0.06 (+0.35%)
US NASDAQ Healthcare Biotechnology
Address
901 Gateway Boulevard 94080
South San Francisco, CA, US
South San Francisco, CA, US
CEO
Rick E. Winningham
Website
theravance.com
IPO
2014-05-16
CIK 1583107 ISIN KYG8807B1068
Description
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD16.98
+0.06 (+0.35%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
486.7K
Beta
0.18
Float Shares
48.20M
Free Float %
93.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.15% | -0.66% | +1.03% | -14.64% | -7.13% | -10.90% | +87.09% | +48.05% | -10.95% | -5.07% | -27.40% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (16 ratings, all time)
Hold
Price Targets & DCF
Current price
16.98
Low
14.00
-17.6%
Consensus
27.00
+59.0%
Median
27.00
+59.0%
High
40.00
+135.6%
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 3 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
14.00
-17.6%
|
| Last Year | 3 |
27.00
+59.0%
|
| All Time | 7 |
20.14
+18.6%
|
Quality scores
Altman Z-Score
1.52
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
2 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+66.9% ★ Q1'26: +15.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+279.1% ★ Q1'26: +64.4% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+80.9% Q1'26: +414.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-12.3% Q1'26: -46.9% (vs Q1'25)
-
ROIC Biotechnology: -16.1%-19.1% Q1'26: +82.2% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+5.5% Q1'26: +3.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-9.77× Q1'26: -2.67× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 5 Rev. Ana. 3 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
42.13M
est: 37.95M (+11.0%)
|
48.65M
est: 47.89M (+1.6%)
|
15.39M
est: 15.80M (-2.6%)
|
60.37M
est: 69.17M (-12.7%)
|
73.41M
est: 58.71M (+25.0%)
|
71.86M
est: 73.90M (-2.8%)
|
55.31M
est: 53.67M (+3.1%)
|
51.35M
est: 51.65M (-0.6%)
|
57.42M
est: 61.51M (-6.6%)
|
64.38M
est: 62.57M (+2.9%)
|
107.46M
est: 128.90M (-16.6%)
|
117.13M
75.89M – 169.66M
-9.1% YoY
|
97.31M
94.19M – 102.22M
-16.9% YoY
|
93.01M
92.71M – 93.31M
-4.4% YoY
|
97.39M
79.49M – 126.57M
+4.7% YoY
|
102.68M
83.80M – 133.44M
+5.4% YoY
|
| EBITDA |
-178.77M
est: -34.13M (-423.7%)
|
-176.04M
est: -160.08M (-10.0%)
|
-259.14M
est: -214.58M (-20.8%)
|
-212.44M
est: -239.69M (+11.4%)
|
-203.60M
est: -206.03M (+1.2%)
|
-287.82M
est: -129.14M (-122.9%)
|
-232.83M
est: -135.91M (-71.3%)
|
-76.08M
est: -106.50M (+28.6%)
|
-51.65M
est: -43.90M (-17.6%)
|
-38.45M
est: -44.66M (+13.9%)
|
-7.73M
est: -92.00M (+91.6%)
|
-83.60M
-121.09M – -54.17M
+9.1% YoY
|
-69.45M
-72.96M – -67.23M
+16.9% YoY
|
-66.38M
-66.59M – -66.17M
+4.4% YoY
|
-69.51M
-90.34M – -56.73M
-4.7% YoY
|
-73.28M
-95.24M – -59.81M
-5.4% YoY
|
| EBIT |
-181.27M
est: -34.82M (-420.5%)
|
-179.16M
est: -163.78M (-9.4%)
|
-263.16M
est: -214.54M (-22.7%)
|
-215.60M
est: -269.66M (+20.0%)
|
-209.82M
est: -256.68M (+18.3%)
|
-294.80M
est: -266.42M (-10.6%)
|
-237.64M
est: -246.99M (+3.8%)
|
-79.12M
est: -244.92M (+67.7%)
|
-53.65M
est: -45.65M (-17.5%)
|
-42.07M
est: -46.44M (+9.4%)
|
-13.25M
est: -95.66M (+86.2%)
|
-86.93M
-125.92M – -56.33M
+9.1% YoY
|
-72.22M
-75.86M – -69.91M
+16.9% YoY
|
-69.03M
-69.25M – -68.81M
+4.4% YoY
|
-72.28M
-93.94M – -59.00M
-4.7% YoY
|
-76.21M
-99.04M – -62.20M
-5.4% YoY
|
| Net Income |
-182.22M
est: -275.99M (+34.0%)
|
-190.67M
est: -171.21M (-11.4%)
|
-285.41M
est: -235.62M (-21.1%)
|
-215.52M
est: -241.77M (+10.9%)
|
-236.46M
est: -240.41M (+1.6%)
|
-278.02M
est: -178.32M (-55.9%)
|
-199.43M
est: -191.10M (-4.4%)
|
872.13M
est: -170.64M (+611.1%)
|
-55.19M
est: -44.77M (-23.3%)
|
-56.42M
est: -58.33M (+3.3%)
|
105.90M
est: 114.54M (-7.5%)
|
106.85M
4.28M – 296.55M
-6.7% YoY
|
66.42M
33.70M – 130.99M
-37.8% YoY
|
47.26M
4.64M – 77.78M
-28.9% YoY
|
46.77M
35.59M – 64.98M
-1.0% YoY
|
57.04M
43.41M – 79.26M
+22.0% YoY
|
| SGA |
90.20M
est: 38.85M (+132.2%)
|
84.51M
est: 49.02M (+72.4%)
|
95.59M
est: 16.17M (+491.1%)
|
97.06M
est: 70.80M (+37.1%)
|
106.08M
est: 60.10M (+76.5%)
|
108.53M
est: 75.64M (+43.5%)
|
99.30M
est: 54.93M (+80.8%)
|
67.07M
est: 52.87M (+26.9%)
|
70.45M
est: 52.81M (+33.4%)
|
69.17M
est: 76.18M (-9.2%)
|
73.65M
est: 156.95M (-53.1%)
|
142.62M
92.41M – 206.58M
-9.1% YoY
|
118.49M
114.69M – 124.46M
-16.9% YoY
|
113.25M
112.88M – 113.61M
-4.4% YoY
|
118.59M
96.79M – 154.12M
+4.7% YoY
|
125.03M
102.04M – 162.49M
+5.4% YoY
|
| EPS |
-5.34
est: -5.65 (+5.5%)
|
-4.26
est: -3.83 (-11.3%)
|
-5.45
est: -4.87 (-11.9%)
|
-3.99
est: -4.11 (+2.8%)
|
-4.25
est: -4.14 (-2.7%)
|
-4.46
est: -4.51 (+1.2%)
|
-2.87
est: -2.67 (-7.4%)
|
-1.26
est: -0.55 (-127.4%)
|
-1.00
est: -0.87 (-15.3%)
|
-1.15
est: -1.05 (-9.9%)
|
2.10
est: 1.97 (+6.7%)
|
2.52
0.08 – 5.76
+27.8% YoY
|
1.35
0.65 – 2.54
-46.2% YoY
|
0.81
0.09 – 1.51
-39.9% YoY
|
0.91
0.69 – 1.26
+11.5% YoY
|
1.11
0.84 – 1.54
+22.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-08 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 3/5 | 5/5 | 5/5 | 3/5 | 4/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-05-01 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
299.79M
OE per share TTM
5.89
Owner's Yield
35.07%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
69.8%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
59
Total invested
100.33M
Insider transactions (90d)
0
Beneficial owners (>5%)
37
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Baupost Group GP, L.L.C.82-3254604 | 14.53M | 19.49% | — | 14.53M | — | 14.53M | HC | Delaware | 2022-02-11 | ↗ |
| 2 | Seth A. Klarman | 14.53M | 19.49% | — | 14.53M | — | 14.53M | HC | Delaware | 2022-02-11 | ↗ |
| 3 | The Baupost Group, L.L.C.04-3402144 | 14.53M | 19.49% | — | 14.53M | — | 14.53M | IA | Delaware | 2022-02-11 | ↗ |
| 4 | GlaxoSmithKline plc | 9.64M | 15.50% | 9.64M | — | 9.64M | — | CO | England and Wales | 2020-02-18 | ↗ |
| 5 | Ph.D. | 7.46M | 11.79% | — | 7.46M | — | 11.00 | HC, IN | — | 2023-04-12 | ↗ |
| 6 | Caraway Jackson Investments LLC | 6.65M | 9.00% | — | 6.65M | — | 6.65M | OO | — | 2022-02-14 | ↗ |
| 7 | EMAI Management, LLC | 6.65M | 9.00% | — | 6.65M | — | 6.65M | OO | — | 2022-02-14 | ↗ |
| 8 | Eli Samaha | 6.65M | 9.00% | — | 6.65M | — | 6.65M | IN | — | 2022-02-14 | ↗ |
| 9 | Madison Avenue GP, LLC | 6.65M | 9.00% | — | 6.65M | — | 6.65M | OO | — | 2022-02-14 | ↗ |
| 10 | Madison Avenue International LP | 6.65M | 9.00% | — | 6.65M | — | 6.65M | OO | — | 2022-02-14 | ↗ |
| 11 | Madison Avenue Partners, LP | 6.65M | 9.00% | — | 6.65M | — | 6.65M | OO | — | 2022-02-14 | ↗ |
| 12 | ANDREW M. WEISS, PH.D. | 6.16M | 8.09% | — | 6.16M | — | 6.16M | HC | USA | 2022-06-16 | ↗ |
| 13 | WAM GP LLC | 6.16M | 8.09% | — | 6.16M | — | 6.16M | HC | DELAWARE | 2022-06-16 | ↗ |
| 14 | WEISS ASSET MANAGEMENT LP | 6.16M | 8.09% | — | 6.16M | — | 6.16M | IA | DELAWARE | 2022-06-16 | ↗ |
| 15 | OrbiMed Capital LLC | 5.46M | 7.40% | 5.46M | — | 5.46M | — | IA | Delaware | 2022-02-11 | ↗ |
| 16 | Steven A. Cohen | 5.14M | 4.00% | — | 5.14M | — | 5.14M | IN | Delaware | 2021-09-07 | ↗ |
| 17 | Point72 Capital Advisors, Inc. | 5.04M | 4.00% | — | 5.04M | — | 5.04M | CO | Delaware | 2021-09-07 | ↗ |
| 18 | 2 | 4.11M | 5.50% | — | — | — | — | OO | Spain | 2022-04-21 | ↗ |
| 19 | Newtyn Management, LLC | 4.10M | 8.40% | 4.10M | — | 4.10M | — | IA | New York | 2024-08-16 | ↗ |
| 20 | BIP GP LLC | 3.81M | 5.00% | — | 3.81M | — | 3.81M | OO | DELAWARE | 2022-06-16 | ↗ |
| 21 | Barclays Bank PLC | 3.40M | 5.05% | 3.37M | — | 3.37M | — | BD | England, United Kingdom | 2023-01-30 | ↗ |
| 22 | Barclays PLC | 3.37M | 5.00% | 3.37M | — | 3.37M | — | HC | England, United Kingdom | 2023-01-30 | ↗ |
| 23 | Adam Katz | 2.76M | 5.50% | — | 2.76M | — | 2.76M | IN | Delaware | 2024-02-14 | ↗ |
| 24 | Andrew Dodge | 2.76M | 5.50% | — | 2.76M | — | 2.76M | IN | Delaware | 2024-02-14 | ↗ |
| 25 | Irenic Capital Evergreen Master Fund LP | 2.76M | 5.50% | — | 2.76M | — | 2.76M | PN | Delaware | 2024-02-14 | ↗ |
| 26 | Irenic Capital Management LP | 2.76M | 5.50% | — | 2.76M | — | 2.76M | IA | Delaware | 2024-02-14 | ↗ |
| 27 | FMR LLC | 2.67M | 3.64% | 1.09M | — | 2.67M | — | HC | Delaware | 2021-10-12 | ↗ |
| 28 | Newtyn TE Partners, LP | 2.50M | 5.10% | 2.50M | — | 2.50M | — | PN | New York | 2024-08-16 | ↗ |
| 29 | OrbiMed Advisors LLC | 517.8K | 0.70% | — | 517.8K | — | — | IA | Delaware | 2022-02-11 | ↗ |
| 30 | Wellington Group Holdings LLP | 250.2K | 0.34% | — | 250.2K | — | — | HC | Delaware | 2021-10-08 | ↗ |
| 31 | Wellington Investment Advisors Holdings LLP | 250.2K | 0.34% | — | 250.2K | — | — | HC | Delaware | 2021-10-08 | ↗ |
| 32 | Wellington Management Group LLP | 250.2K | 0.34% | — | 250.2K | — | — | HC | Delaware | 2021-10-08 | ↗ |
| 33 | Point72 Asset Management, L.P. | 145.1K | 4.00% | — | — | — | — | PN | Hong Kong | 2022-02-14 | ↗ |
| 34 | Cubist Systematic Strategies, LLC | 107.1K | 4.00% | — | 107.1K | — | 107.1K | OO | Delaware | 2021-09-07 | ↗ |
| 35 | Point72 Hong Kong Limited | 2.3K | 4.00% | — | 2.3K | — | 2.3K | OO | Delaware | 2021-09-07 | ↗ |
| 36 | Acacia Research Corporation | — | 0.00% | — | — | — | — | CO | Delaware | 2020-06-11 | ↗ |
| 37 | Link Fund Solutions Limited | — | 0.00% | — | — | — | — | CO | United Kingdom | 2020-06-23 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
59
-112 vs prev Q
New positions
20
Closed positions
130
Increased
38
Reduced
10
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 208.8K +208.8K (+100.0%) | 3.91B +3.9B (+100.0%) | 0.41% +0.413 pp | 0.01% +0.006 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 2 | MADISON AVENUE PARTNERS, LP | 9.51M +— (+0.0%) | 177.95M +39.1M (+28.2%) | 18.83% -0.129 pp | 7.65% -0.642 pp | USD8.42 +122.2% | 18 qtrs — |
| 3 | WEISS ASSET MANAGEMENT LP | 7.46M +— (+0.0%) | 139.52M +30.6M (+28.2%) | 14.76% -0.101 pp | 1.95% +0.678 pp | USD10.12 +84.9% | 17 qtrs — |
| 4 | NEWTYN MANAGEMENT, LLC | 4.30M -650.0K (-13.1%) | 80.45M +8.2M (+11.3%) | 8.51% -1.354 pp | 8.45% -0.393 pp | USD8.92 +109.8% | 18 qtrs — |
| 5 | BLACKROCK, INC. | 4.05M -18.5K (-0.5%) | 75.79M +16.4M (+27.6%) | 8.02% -0.092 pp | 0.00% +0.000 pp | USD8.55 +118.8% | 6 qtrs — |
| 6 | IRENIC CAPITAL MANAGEMENT LP | 2.76M +— (+0.0%) | 51.66M +11.3M (+28.2%) | 5.47% -0.037 pp | 3.47% -0.748 pp | USD11.08 +68.9% | 13 qtrs — |
| 7 | VANGUARD GROUP INC | 2.37M +155.8K (+7.0%) | 44.29M +12.0M (+37.2%) | 4.69% +0.278 pp | 0.00% +0.000 pp | USD20.00 -6.5% | 47 qtrs — |
| 8 | D. E. SHAW & CO., INC. | 1.26M +50.6K (+4.2%) | 23.57M +5.9M (+33.5%) | 2.49% +0.084 pp | 0.01% +0.003 pp | USD10.93 +71.2% | 24 qtrs — |
| 9 | ACADIAN ASSET MANAGEMENT LLC | 1.17M +76.6K (+7.0%) | 21.81M +5.9M (+37.2%) | 2.31% +0.137 pp | 0.04% +0.008 pp | USD13.61 +37.5% | 6 qtrs — |
| 10 | STATE STREET CORP | 1.10M +46.0K (+4.4%) | 20.62M +5.2M (+33.7%) | 2.18% +0.077 pp | 0.00% +0.000 pp | USD20.83 -10.2% | 47 qtrs — |
| 11 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 963.3K +236.5K (+32.5%) | 18.02M +7.4M (+69.8%) | 1.91% +0.458 pp | 0.01% +0.004 pp | USD15.61 +19.9% | 4 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 938.7K +40.7K (+4.5%) | 17.57M +4.5M (+34.0%) | 1.86% +0.069 pp | 0.00% +0.000 pp | USD17.94 +4.3% | 47 qtrs — |
| 13 | DIMENSIONAL FUND ADVISORS LP | 859.0K +92.3K (+12.0%) | 16.07M +4.9M (+43.6%) | 1.70% +0.172 pp | 0.00% +0.001 pp | USD10.64 +75.8% | 11 qtrs — |
| 14 | MORGAN STANLEY | 803.1K +203.6K (+34.0%) | 15.03M +6.3M (+71.7%) | 1.59% +0.395 pp | 0.00% +0.000 pp | USD12.76 +46.6% | 47 qtrs — |
| 15 | OASIS MANAGEMENT CO LTD. | 727.2K -391.8K (-35.0%) | 13.61M -2.7M (-16.7%) | 1.44% -0.791 pp | 0.88% -0.693 pp | USD9.85 +89.9% | 14 qtrs — |
| 16 | UBS GROUP AG | 570.4K +56.3K (+10.9%) | 10.67M +3.2M (+42.2%) | 1.13% +0.104 pp | 0.00% +0.001 pp | USD11.25 +66.3% | 45 qtrs — |
| 17 | TWO SIGMA INVESTMENTS, LP | 537.3K +306.1K (+132.3%) | 10.05M +6.7M (+197.7%) | 1.06% +0.603 pp | 0.01% +0.009 pp | USD16.82 +11.2% | 3 qtrs — |
| 18 | QUBE RESEARCH & TECHNOLOGIES LTD | 473.5K +262.5K (+124.4%) | 8.86M +5.8M (+187.5%) | 0.94% +0.517 pp | 0.01% +0.006 pp | USD14.83 +26.2% | 4 qtrs — |
| 19 | MARSHALL WACE, LLP | 418.6K +61.0K (+17.0%) | 7.83M +2.6M (+50.0%) | 0.83% +0.116 pp | 0.01% +0.002 pp | USD14.26 +31.2% | 11 qtrs — |
| 20 | JPMORGAN CHASE & CO | 416.4K +203.3K (+95.4%) | 7.79M +4.7M (+150.4%) | 0.82% +0.400 pp | 0.00% +0.000 pp | USD14.89 +25.7% | 41 qtrs — |
| 21 | ASSENAGON ASSET MANAGEMENT S.A. | 404.1K -10.6K (-2.5%) | 7.56M +1.5M (+24.9%) | 0.80% -0.027 pp | 0.01% +0.002 pp | USD14.39 +30.0% | 3 qtrs — |
| 22 | JANUS HENDERSON GROUP PLC | 400.5K +273.3K (+214.8%) | 7.49M +5.6M (+303.5%) | 0.79% +0.539 pp | 0.00% +0.003 pp | USD17.40 +7.5% | 2 qtrs — |
| 23 | TWO SIGMA ADVISERS, LP | 379.5K +179.2K (+89.5%) | 7.10M +4.2M (+142.8%) | 0.75% +0.352 pp | 0.01% +0.008 pp | USD16.13 +16.0% | 4 qtrs — |
| 24 | TANG CAPITAL MANAGEMENT LLC | 351.3K +86.9K (+32.9%) | 6.57M +2.7M (+70.3%) | 0.70% +0.169 pp | 0.32% +0.176 pp | USD10.71 +74.7% | 6 qtrs — |
| 25 | PACER ADVISORS, INC. | 339.0K +339.0K (+100.0%) | 6.34M +6.3M (+100.0%) | 0.67% +0.671 pp | 0.02% +0.016 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 26 | NORTHERN TRUST CORP | 329.9K -11.4K (-3.3%) | 6.17M +1.2M (+23.9%) | 0.65% -0.027 pp | 0.00% +0.000 pp | USD25.81 -27.5% | 47 qtrs — |
| 27 | BNP PARIBAS ARBITRAGE, SNC | 324.3K -49.3K (-13.2%) | 6.07M +613.4K (+11.2%) | 0.64% -0.103 pp | 0.00% 0.000 pp | USD9.12 +105.2% | 46 qtrs — |
| 28 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 313.3K -6.9K (-2.1%) | 5.86M +1.2M (+25.4%) | 0.62% -0.018 pp | 0.00% +0.000 pp | USD19.63 -4.7% | 47 qtrs — |
| 29 | HILLSDALE INVESTMENT MANAGEMENT INC. | 308.6K -2.1K (-0.7%) | 5.77M +1.2M (+27.3%) | 0.61% -0.008 pp | 0.16% +0.022 pp | USD14.60 +28.2% | 2 qtrs — |
| 30 | GOLDMAN SACHS GROUP INC | 290.9K +32.2K (+12.5%) | 5.44M +1.7M (+44.1%) | 0.58% +0.060 pp | 0.00% +0.000 pp | USD13.01 +43.8% | 42 qtrs — |
| 31 | CITADEL ADVISORS LLC | 235.7K +184.8K (+363.4%) | 4.41M +3.7M (+493.8%) | 0.47% +0.365 pp | 0.00% +0.001 pp | USD16.74 +11.8% | 17 qtrs — |
| 32 | HRT FINANCIAL LP | 232.9K +209.4K (+892.8%) | 4.36M +4.0M (+1,173.7%) | 0.46% +0.414 pp | 0.01% +0.013 pp | USD17.87 +4.7% | 4 qtrs — |
| 33 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 221.7K +46.8K (+26.8%) | 4.15M +1.6M (+62.5%) | 0.44% +0.090 pp | 0.01% +0.003 pp | USD14.56 +28.5% | 3 qtrs — |
| 34 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 208.8K +208.8K (+100.0%) | 3.91M +3.9M (+100.0%) | 0.41% +0.413 pp | 0.20% +0.200 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 35 | TUDOR INVESTMENT CORP ET AL | 190.1K +139.1K (+272.5%) | 3.56M +2.8M (+377.3%) | 0.38% +0.275 pp | 0.01% +0.005 pp | USD16.12 +16.1% | 18 qtrs — |
| 36 | TREXQUANT INVESTMENT LP | 182.5K +38.0K (+26.3%) | 3.41M +1.3M (+61.8%) | 0.36% +0.073 pp | 0.03% +0.009 pp | USD10.74 +74.2% | 7 qtrs — |
| 37 | PARK WEST ASSET MANAGEMENT LLC | 181.5K -1.1M (-85.9%) | 3.40M -15.4M (-81.9%) | 0.36% -2.200 pp | 0.28% -1.298 pp | USD8.81 +112.4% | 16 qtrs — |
| 38 | INVESCO LTD. | 177.9K +153.3K (+622.2%) | 3.33M +3.0M (+825.5%) | 0.35% +0.303 pp | 0.00% +0.001 pp | USD17.50 +6.9% | 21 qtrs — |
| 39 | WELLS FARGO & COMPANY/MN | 174.4K +149.7K (+604.6%) | 3.26M +2.9M (+803.0%) | 0.35% +0.296 pp | 0.00% +0.001 pp | USD17.63 +6.1% | 47 qtrs — |
| 40 | MILLENNIUM MANAGEMENT LLC | 137.0K +112.5K (+459.3%) | 2.56M +2.2M (+616.7%) | 0.27% +0.222 pp | 0.00% +0.001 pp | USD16.95 +10.4% | 22 qtrs — |
| 41 | LOS ANGELES CAPITAL MANAGEMENT LLC | 174.5K -6.9K (-3.8%) | 2.50M -153.7K (-5.8%) | 0.35% -0.016 pp | 0.01% -0.001 pp | USD14.21 +31.7% | 3 qtrs — |
| 42 | WELLINGTON MANAGEMENT GROUP LLP | 123.0K -7.2K (-5.5%) | 2.30M +400.5K (+21.1%) | 0.24% -0.016 pp | 0.00% +0.000 pp | USD14.03 +33.4% | 25 qtrs — |
| 43 | BANK OF NEW YORK MELLON CORP | 118.5K +4.0K (+3.5%) | 2.22M +545.3K (+32.6%) | 0.23% +0.006 pp | 0.00% +0.000 pp | USD23.94 -21.8% | 47 qtrs — |
| 44 | MAN GROUP PLC | 117.1K +37.3K (+46.7%) | 2.19M +1.0M (+88.0%) | 0.23% +0.073 pp | 0.00% +0.002 pp | USD15.91 +17.6% | 2 qtrs — |
| 45 | BARCLAYS PLC | 111.6K +46.0K (+70.2%) | 2.09M +1.6M (+295.1%) | 0.22% +0.090 pp | 0.00% +0.000 pp | USD13.71 +36.5% | 47 qtrs — |
| 46 | BANK OF AMERICA CORP /DE/ | 106.2K -420.9K (-79.9%) | 1.99M -5.7M (-74.2%) | 0.21% -0.840 pp | 0.00% 0.000 pp | USD10.36 +80.6% | 47 qtrs — |
| 47 | INTEGRATED QUANTITATIVE INVESTMENTS LLC | 105.1K +80.0K (+317.7%) | 1.97M +1.6M (+435.3%) | 0.21% +0.158 pp | 0.42% +0.318 pp | USD17.73 +5.5% | 2 qtrs — |
| 48 | AMERICAN CENTURY COMPANIES INC | 104.3K +8.6K (+8.9%) | 1.95M +553.7K (+39.6%) | 0.21% +0.016 pp | 0.00% +0.000 pp | USD10.71 +74.7% | 13 qtrs — |
| 49 | PDT PARTNERS, LLC | 92.6K -17.2K (-15.6%) | 1.73M +130.0K (+8.1%) | 0.18% -0.035 pp | 0.11% +0.011 pp | USD9.61 +94.7% | 17 qtrs — |
| 50 | FRANKLIN RESOURCES INC | 90.7K -1.7K (-1.8%) | 1.70M +348.2K (+25.8%) | 0.18% -0.005 pp | 0.00% +0.000 pp | USD12.68 +47.6% | 16 qtrs — |
| 51 | NUVEEN, LLC | 89.0K -3.2K (-3.5%) | 1.66M +318.6K (+23.7%) | 0.18% -0.008 pp | 0.00% +0.000 pp | USD8.93 +109.5% | 4 qtrs — |
| 52 | ALLIANCEBERNSTEIN L.P. | 70.1K +— (+0.0%) | 1.31M +288.0K (+28.2%) | 0.14% -0.001 pp | 0.00% +0.000 pp | USD20.03 -6.6% | 47 qtrs — |
| 53 | INSPIRE INVESTING, LLC | 68.5K -5.0K (-6.8%) | 1.28M +208.2K (+19.4%) | 0.14% -0.011 pp | 0.12% +0.011 pp | USD14.60 +28.2% | 2 qtrs — |
| 54 | SQUAREPOINT OPS LLC | 67.4K +20.6K (+44.1%) | 1.26M +577.7K (+84.6%) | 0.13% +0.040 pp | 0.00% +0.001 pp | USD14.65 +27.7% | 18 qtrs — |
| 55 | MARTINGALE ASSET MANAGEMENT L P | 66.5K -4.5K (-6.4%) | 1.24M +207.3K (+20.0%) | 0.13% -0.010 pp | 0.03% +0.006 pp | USD10.74 +74.2% | 13 qtrs — |
| 56 | EAM INVESTORS, LLC | 66.3K +38.0 (+0.1%) | 1.24M +273.0K (+28.2%) | 0.13% -0.001 pp | 0.14% +0.027 pp | USD14.60 +28.2% | 2 qtrs — |
| 57 | PRICE T ROWE ASSOCIATES INC /MD/ | 66.1K +2.0K (+3.1%) | 1.24M +300.0K (+32.0%) | 0.13% +0.003 pp | 0.00% +0.000 pp | USD13.98 +33.8% | 47 qtrs — |
| 58 | WINTON GROUP LTD | 64.8K -11.8K (-15.4%) | 1.21M +94.3K (+8.4%) | 0.13% -0.024 pp | 0.04% +0.000 pp | USD14.60 +28.2% | 2 qtrs — |
| 59 | SIERRA SUMMIT ADVISORS LLC | 59.4K +59.4K (+100.0%) | 1.11M +1.1M (+100.0%) | 0.12% +0.118 pp | 0.17% +0.170 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 60 | GSA CAPITAL PARTNERS LLP | 58.4K -33.8K (-36.7%) | 1.09M -254.0K (-18.9%) | 0.12% -0.068 pp | 0.09% -0.018 pp | USD8.52 +119.6% | 16 qtrs — |
| 61 | MILITIA CAPITAL PARTNERS, LP | 54.2K +— (+0.0%) | 1.01M +222.8K (+28.2%) | 0.11% -0.001 pp | 0.37% +0.010 pp | USD11.03 +69.6% | 3 qtrs — |
| 62 | CANADA PENSION PLAN INVESTMENT BOARD | 49.7K +49.7K (+100.0%) | 929.9K +929.9K (+100.0%) | 0.10% +0.098 pp | 0.00% +0.001 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 63 | RHUMBLINE ADVISERS | 49.0K -6.6K (-11.9%) | 917.1K +104.7K (+12.9%) | 0.10% -0.014 pp | 0.00% +0.000 pp | USD17.71 +5.6% | 47 qtrs — |
| 64 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 43.4K +29.3K (+208.8%) | 811.1K +606.1K (+295.8%) | 0.09% +0.058 pp | 0.01% +0.009 pp | USD17.38 +7.7% | 2 qtrs — |
| 65 | JUMP FINANCIAL, LLC | 42.0K +1.2K (+2.9%) | 785.6K +189.9K (+31.9%) | 0.08% +0.002 pp | 0.01% +0.003 pp | USD11.25 +66.3% | 3 qtrs — |
| 66 | ALPS ADVISORS INC | 41.6K +17.4K (+71.8%) | 778.5K +425.0K (+120.2%) | 0.08% +0.034 pp | 0.00% +0.003 pp | USD12.81 +46.1% | 7 qtrs — |
| 67 | ENGINEERS GATE MANAGER LP | 41.0K +18.7K (+84.0%) | 767.3K +441.9K (+135.8%) | 0.08% +0.037 pp | 0.01% +0.005 pp | USD15.29 +22.4% | 9 qtrs — |
| 68 | SEI INVESTMENTS CO | 40.7K +40.7K (+100.0%) | 761.9K +761.9K (+100.0%) | 0.08% +0.081 pp | 0.00% +0.001 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 69 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 38.2K +559.0 (+1.5%) | 714.2K +165.0K (+30.1%) | 0.08% +0.001 pp | 0.00% +0.000 pp | USD8.69 +115.3% | 7 qtrs — |
| 70 | MACKENZIE FINANCIAL CORP | 37.3K +37.3K (+100.0%) | 704.5K +704.5K (+100.0%) | 0.07% +0.074 pp | 0.00% +0.001 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 71 | VIRTUS INVESTMENT ADVISERS, INC. | 37.6K -4.3K (-10.2%) | 703.7K +92.2K (+15.1%) | 0.07% -0.009 pp | 0.19% +0.016 pp | USD9.21 +103.1% | 4 qtrs — |
| 72 | CAMPBELL & CO INVESTMENT ADVISER LLC | 36.5K -16.1K (-30.6%) | 682.9K -85.3K (-11.1%) | 0.07% -0.033 pp | 0.03% -0.025 pp | USD11.18 +67.4% | 3 qtrs — |
| 73 | STRS OHIO | 36.3K -7.8K (-17.7%) | 679.2K +35.3K (+5.5%) | 0.07% -0.016 pp | 0.00% +0.000 pp | USD14.60 +28.2% | 2 qtrs — |
| 74 | NUMERAI GP LLC | 35.8K +7.6K (+27.0%) | 670.7K +258.5K (+62.7%) | 0.07% +0.015 pp | 0.08% +0.023 pp | USD15.47 +20.9% | 2 qtrs — |
| 75 | ELLSWORTH ADVISORS, LLC | 33.3K +33.3K (+100.0%) | 670.3K +670.3K (+100.0%) | 0.07% +0.066 pp | 0.13% +0.133 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 76 | ENTRYPOINT CAPITAL, LLC | 34.6K +4.3K (+14.3%) | 646.9K +205.2K (+46.4%) | 0.07% +0.008 pp | 0.25% +0.081 pp | USD12.23 +53.0% | 3 qtrs — |
| 77 | BROOKWOOD INVESTMENT GROUP LLC | 32.4K +11.3K (+53.6%) | 605.6K +297.9K (+96.8%) | 0.06% +0.022 pp | 0.07% +0.033 pp | USD12.34 +51.6% | 4 qtrs — |
| 78 | JACOBS LEVY EQUITY MANAGEMENT, INC | 30.4K -10.1K (-24.9%) | 569.6K -22.2K (-3.8%) | 0.06% -0.021 pp | 0.00% 0.000 pp | USD13.92 +34.4% | 33 qtrs — |
| 79 | DEUTSCHE BANK AG\ | 27.1K +1.4K (+5.5%) | 506.5K +132.0K (+35.3%) | 0.05% +0.003 pp | 0.00% +0.000 pp | USD12.54 +49.2% | 47 qtrs — |
| 80 | AVIVA PLC | 26.8K +26.8K (+100.0%) | 501.6K +501.6K (+100.0%) | 0.05% +0.053 pp | 0.00% +0.001 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 81 | LEGATO CAPITAL MANAGEMENT LLC | 26.2K +26.2K (+100.0%) | 489.4K +489.4K (+100.0%) | 0.05% +0.052 pp | 0.04% +0.042 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 82 | DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 25.5K +— (+0.0%) | 477.8K +104.9K (+28.2%) | 0.05% 0.000 pp | 0.00% +0.000 pp | USD14.60 +28.2% | 2 qtrs — |
| 83 | STATE OF WYOMING | 24.9K -5.9K (-19.1%) | 465.6K +16.7K (+3.7%) | 0.05% -0.012 pp | 0.05% 0.000 pp | USD10.92 +71.3% | 7 qtrs — |
| 84 | AQR CAPITAL MANAGEMENT LLC | 24.7K +5.8K (+31.1%) | 461.8K +186.8K (+67.9%) | 0.05% +0.011 pp | 0.00% +0.000 pp | USD12.84 +45.7% | 4 qtrs — |
| 85 | STERLING CAPITAL MANAGEMENT LLC | 23.7K +54.0 (+0.2%) | 442.9K +98.1K (+28.4%) | 0.05% 0.000 pp | 0.01% +0.002 pp | USD14.55 +28.6% | 6 qtrs — |
| 86 | GOTHAM ASSET MANAGEMENT, LLC | 22.7K +22.7K (+100.0%) | 424.3K +424.3K (+100.0%) | 0.04% +0.045 pp | 0.00% +0.002 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 87 | BAADER BANK AKTIENGESELLSCHAFT | 22.1K -31.4K (-58.7%) | 412.8K -368.3K (-47.2%) | 0.04% -0.063 pp | 0.03% -0.022 pp | USD14.60 +28.2% | 2 qtrs — |
| 88 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21.9K +1.6K (+7.9%) | 409.7K +113.4K (+38.3%) | 0.04% +0.003 pp | 0.00% +0.000 pp | USD9.65 +93.9% | 18 qtrs — |
| 89 | METLIFE INVESTMENT MANAGEMENT, LLC | 21.7K -2.9K (-11.7%) | 406.9K +47.3K (+13.1%) | 0.04% -0.006 pp | 0.00% +0.000 pp | USD13.42 +39.4% | 30 qtrs — |
| 90 | INTECH INVESTMENT MANAGEMENT LLC | 20.4K -2.2K (-9.8%) | 382.5K +51.4K (+15.5%) | 0.04% -0.005 pp | 0.00% +0.001 pp | USD9.26 +102.1% | 5 qtrs — |
| 91 | QUANTBOT TECHNOLOGIES LP | 19.3K -7.2K (-27.0%) | 362.0K -25.1K (-6.5%) | 0.04% -0.015 pp | 0.01% +0.002 pp | USD14.60 +28.2% | 2 qtrs — |
| 92 | HSBC HOLDINGS PLC | 18.5K -30.4K (-62.2%) | 353.7K -364.9K (-50.8%) | 0.04% -0.061 pp | 0.00% 0.000 pp | USD11.03 +69.6% | 3 qtrs — |
| 93 | Y-INTERCEPT (HONG KONG) LTD | 18.7K +18.7K (+100.0%) | 349.6K +349.6K (+100.0%) | 0.04% +0.037 pp | 0.01% +0.008 pp | USD18.71 +0.0% | 3 qtrs — |
| 94 | STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 17.7K +— (+0.0%) | 330.8K +72.7K (+28.2%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD24.24 -22.8% | 47 qtrs — |
| 95 | MAGNETAR FINANCIAL LLC | 17.0K +17.0K (+100.0%) | 317.6K +317.6K (+100.0%) | 0.03% +0.034 pp | 0.00% +0.003 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 96 | PRUDENTIAL FINANCIAL INC | 16.7K +16.7K (+100.0%) | 311.8K +311.8K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD18.71 +0.0% | 1 qtrs NEW |
| 97 | JANE STREET GROUP, LLC | 16.6K +2.8K (+20.3%) | 310.6K +109.1K (+54.2%) | 0.03% +0.005 pp | 0.00% +0.000 pp | USD15.29 +22.4% | 2 qtrs — |
| 98 | SCHONFELD STRATEGIC ADVISORS LLC | 16.6K +16.6K (+100.0%) | 309.7K +309.7K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.001 pp | USD18.71 +0.0% | 1 qtrs NEW |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 105 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech ETF BBP | 1.31% | 1.29M | 0.34% |
| 2 | State Street SPDR S&P Pharmaceuticals ETF XPH | 0.91% | 4.28M | 0.35% |
| 3 | Janus Henderson Small Cap Growth Alpha ETF JSML | 0.59% | 2.18M | 0.30% |
| 4 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.53% | 115.6K | 0.20% |
| 5 | ALPS Medical Breakthroughs ETF SBIO | 0.45% | 953.1K | 0.50% |
| 6 | Global X - Aging Population ETF AGNG | 0.31% | 261.3K | 0.50% |
| 7 | Franklin Small Cap Enhanced ETF FSML | 0.21% | 316.5K | 0.45% |
| 8 | Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL | 0.19% | 43.9K | 1.22% |
| 9 | iShares Micro-Cap ETF IWC | 0.15% | 2.28M | 0.60% |
| 10 | iShares U.S. Pharmaceuticals ETF IHE | 0.14% | 1.93M | 0.38% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
168.8K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+168,750
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Winningham Rick E | Director / Officer | A-Award | A | Ordinary Shares | 75,000 | 0.00 | — | 1,651,094 | D | ↗ |
| 2026-04-01 | Sawaf Aziz | Officer | A-Award | A | Ordinary Shares | 37,500 | 0.00 | — | 353,623 | D | ↗ |
| 2026-04-01 | Grimaud Brett A. | Officer | A-Award | A | Ordinary Shares | 37,500 | 0.00 | — | 371,949 | D | ↗ |
| 2026-04-01 | Farnum Rhonda | Officer | A-Award | A | Ordinary Shares | 18,750 | 0.00 | — | 251,449 | D | ↗ |
| 2026-03-16 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 7,767 | 13.92 | 108.1K | 255,999 | D | ↗ |
| 2026-02-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 74,975 | 19.66 | 1.47M | 1,576,094 | D | ↗ |
| 2026-02-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 20,672 | 19.66 | 406.4K | 316,123 | D | ↗ |
| 2026-02-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 16,851 | 19.66 | 331.3K | 184,161 | D | ↗ |
| 2026-02-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 20,833 | 19.66 | 409.6K | 334,449 | D | ↗ |
| 2026-02-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 13,929 | 19.66 | 273.8K | 263,766 | D | ↗ |
| 2025-12-03 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 7,767 | 18.75 | 145.6K | 300,995 | D | ↗ |
| 2025-11-26 | BROSHY ERAN | Director | M-Exempt | A | Share Option (Right to Buy) | 14,000 | 10.15 | 142.1K | 81,749 | D | ↗ |
| 2025-11-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 56,817 | 17.90 | 1.02M | 1,651,069 | D | ↗ |
| 2025-11-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 18,627 | 17.90 | 333.4K | 336,795 | D | ↗ |
| 2025-11-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 6,989 | 17.90 | 125.1K | 201,012 | D | ↗ |
| 2025-11-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 19,024 | 17.90 | 340.5K | 355,282 | D | ↗ |
| 2025-11-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 9,060 | 17.90 | 162.2K | 308,762 | D | ↗ |
| 2025-11-19 | Winningham Rick E | Director / Officer | G-Gift | A | Ordinary Shares | 9,900 | 0.00 | — | 23,400 | I | ↗ |
| 2025-11-11 | BROSHY ERAN | Director | S-Sale | D | Ordinary Shares | 15,500 | 18.50 | 286.8K | 75,704 | D | ↗ |
| 2025-08-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,394 | 13.39 | 206.1K | 1,717,786 | D | ↗ |
| 2025-08-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 9,368 | 13.39 | 125.4K | 355,422 | D | ↗ |
| 2025-08-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 6,989 | 13.39 | 93.6K | 208,001 | D | ↗ |
| 2025-08-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 9,762 | 13.39 | 130.7K | 374,306 | D | ↗ |
| 2025-08-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 9,096 | 13.39 | 121.8K | 317,822 | D | ↗ |
| 2025-07-14 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 682 | 11.39 | 7.8K | 336,236 | D | ↗ |
| 2025-06-23 | Winningham Rick E | Director / Officer | G-Gift | D | Ordinary Shares | 20,000 | 0.00 | — | 1,733,180 | D | ↗ |
| 2025-06-13 | Winningham Rick E | Director / Officer | G-Gift | D | Ordinary Shares | 9,600 | 0.00 | — | 1,753,180 | D | ↗ |
| 2025-06-02 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 24,000 | 11.00 | 264.0K | 336,918 | D | ↗ |
| 2025-05-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,364 | 9.45 | 145.2K | 1,762,780 | D | ↗ |
| 2025-05-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 9,348 | 9.45 | 88.3K | 364,790 | D | ↗ |
| 2025-05-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 9,701 | 9.45 | 91.7K | 214,990 | D | ↗ |
| 2025-05-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 9,743 | 9.45 | 92.1K | 384,068 | D | ↗ |
| 2025-05-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 9,120 | 9.45 | 86.2K | 360,918 | D | ↗ |
| 2025-05-19 | Smaldone Alsup Laurie | Director | A-Award | A | Share Option (Right to Buy) | 24,258 | 9.39 | 227.8K | 24,258 | D | ↗ |
| 2025-05-19 | PAKIANATHAN DEEPIKA | Director | A-Award | A | Share Option (Right to Buy) | 24,258 | 9.39 | 227.8K | 24,258 | D | ↗ |
| 2025-05-19 | O'Connor Donal | Director | A-Award | A | Share Option (Right to Buy) | 24,258 | 9.39 | 227.8K | 24,258 | D | ↗ |
| 2025-05-19 | Miller Aine | Officer | A-Award | A | Ordinary Shares | 10,430 | 0.00 | — | 224,691 | D | ↗ |
| 2025-05-19 | MITCHELL DEAN J | Director | A-Award | A | Share Option (Right to Buy) | 24,258 | 9.39 | 227.8K | 24,258 | D | ↗ |
| 2025-05-19 | Grant Jeremy T | Director | A-Award | A | Share Option (Right to Buy) | 24,258 | 9.39 | 227.8K | 24,258 | D | ↗ |
| 2025-05-19 | GRAY SUSANNAH | Director | A-Award | A | Ordinary Shares | 10,649 | 0.00 | — | 42,137 | D | ↗ |
| 2025-05-19 | BROSHY ERAN | Director | A-Award | A | Share Option (Right to Buy) | 24,258 | 9.39 | 227.8K | 24,258 | D | ↗ |
| 2025-04-21 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 4,000 | 9.00 | 36.0K | 370,038 | D | ↗ |
| 2025-02-28 | Winningham Rick E | Director / Officer | A-Award | A | Ordinary Shares | 2,178 | 9.35 | 20.4K | 1,778,144 | D | ↗ |
| 2025-02-28 | Sawaf Aziz | Officer | A-Award | A | Ordinary Shares | 75,000 | 0.00 | — | 374,138 | D | ↗ |
| 2025-02-28 | Miller Aine | Officer | A-Award | A | Ordinary Shares | 75,000 | 0.00 | — | 214,261 | D | ↗ |
| 2025-02-28 | Grimaud Brett A. | Officer | A-Award | A | Ordinary Shares | 75,000 | 0.00 | — | 393,811 | D | ↗ |
| 2025-02-28 | Farnum Rhonda | Officer | A-Award | A | Ordinary Shares | 75,000 | 0.00 | — | 374,038 | D | ↗ |
| 2025-02-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 35,129 | 9.66 | 339.3K | 1,775,966 | D | ↗ |
| 2025-02-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 13,751 | 9.66 | 132.8K | 299,138 | D | ↗ |
| 2025-02-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 11,295 | 9.66 | 109.1K | 139,261 | D | ↗ |
| 2025-02-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 14,534 | 9.66 | 140.4K | 318,811 | D | ↗ |
| 2025-02-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 15,810 | 9.66 | 152.7K | 299,038 | D | ↗ |
| 2025-02-10 | Farnum Rhonda | Officer | A-Award | A | Ordinary Shares | 5,283 | 0.00 | — | 314,848 | D | ↗ |
| 2025-01-21 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 4,000 | 9.00 | 36.0K | 309,565 | D | ↗ |
| 2024-11-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,997 | 9.97 | 159.5K | 1,811,095 | D | ↗ |
| 2024-11-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 8,477 | 9.97 | 84.5K | 312,889 | D | ↗ |
| 2024-11-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 10,076 | 9.97 | 100.5K | 150,556 | D | ↗ |
| 2024-11-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 9,268 | 9.97 | 92.4K | 333,345 | D | ↗ |
| 2024-11-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 9,178 | 9.97 | 91.5K | 313,565 | D | ↗ |
| 2024-11-14 | Winningham Rick E | Director / Officer | A-Award | A | Ordinary Shares | 3,193 | 9.57 | 30.6K | 1,827,092 | D | ↗ |
| 2024-11-11 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 4,000 | 9.00 | 36.0K | 322,743 | D | ↗ |
| 2024-08-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,997 | 8.22 | 131.5K | 1,823,899 | — | ↗ |
| 2024-08-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 8,635 | 8.22 | 71.0K | 321,366 | — | ↗ |
| 2024-08-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 5,201 | 8.22 | 42.8K | 160,632 | — | ↗ |
| 2024-08-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 9,268 | 8.22 | 76.2K | 342,613 | — | ↗ |
| 2024-08-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 9,222 | 8.22 | 75.8K | 326,743 | — | ↗ |
| 2024-08-07 | Winningham Rick E | Director / Officer | A-Award | A | Ordinary Shares | 3,252 | 7.83 | 25.5K | 1,839,896 | — | ↗ |
| 2024-07-10 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 4,000 | 9.00 | 36.0K | 335,965 | — | ↗ |
| 2024-05-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,997 | 9.10 | 145.6K | 1,836,644 | — | ↗ |
| 2024-05-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 8,635 | 9.10 | 78.6K | 330,001 | — | ↗ |
| 2024-05-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 5,201 | 9.10 | 47.3K | 165,833 | — | ↗ |
| 2024-05-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 9,268 | 9.10 | 84.3K | 351,881 | — | ↗ |
| 2024-05-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 9,268 | 9.10 | 84.3K | 339,965 | — | ↗ |
| 2024-05-15 | Winningham Rick E | Director / Officer | A-Award | A | Ordinary Shares | 2,068 | 9.85 | 20.4K | 1,852,641 | — | ↗ |
| 2024-05-08 | Smaldone Alsup Laurie | Director | A-Award | A | Share Option (Right to Buy) | 23,576 | 9.49 | 223.7K | 23,576 | — | ↗ |
| 2024-05-08 | PAKIANATHAN DEEPIKA | Director | A-Award | A | Share Option (Right to Buy) | 23,576 | 9.49 | 223.7K | 23,576 | — | ↗ |
| 2024-05-08 | O'Connor Donal | Director | A-Award | A | Share Option (Right to Buy) | 23,576 | 9.49 | 223.7K | 23,576 | — | ↗ |
| 2024-05-08 | MITCHELL DEAN J | Director | A-Award | A | Share Option (Right to Buy) | 23,576 | 9.49 | 223.7K | 23,576 | — | ↗ |
| 2024-05-08 | Grant Jeremy T | Director | A-Award | A | Ordinary Shares | 10,537 | 0.00 | — | 22,305 | — | ↗ |
| 2024-05-08 | GRAY SUSANNAH | Director | A-Award | A | Share Option (Right to Buy) | 23,576 | 9.49 | 223.7K | 23,576 | — | ↗ |
| 2024-05-08 | BROSHY ERAN | Director | A-Award | A | Share Option (Right to Buy) | 23,576 | 9.49 | 223.7K | 23,576 | — | ↗ |
| 2024-05-01 | Samaha Eli | 10% Owner | P-Purchase | A | COM | 499,324 | 8.75 | 4.37M | 8,511,350 | — | ↗ |
| 2024-04-02 | Winningham Rick E | Director / Officer | A-Award | A | Ordinary Shares | 300,000 | 0.00 | — | 1,850,573 | — | ↗ |
| 2024-04-02 | Sawaf Aziz | Officer | A-Award | A | Ordinary Shares | 100,000 | 0.00 | — | 338,636 | — | ↗ |
| 2024-04-02 | Miller Aine | Officer | A-Award | A | Ordinary Shares | 37,500 | 0.00 | — | 171,034 | — | ↗ |
| 2024-04-02 | Grimaud Brett A. | Officer | A-Award | A | Ordinary Shares | 100,000 | 0.00 | — | 360,684 | — | ↗ |
| 2024-04-02 | Farnum Rhonda | Officer | A-Award | A | Ordinary Shares | 37,500 | 0.00 | — | 349,233 | — | ↗ |
| 2024-03-15 | Winningham Rick E | Director / Officer | G-Gift | A | Ordinary Shares | 3,900 | 0.00 | — | 3,900 | — | ↗ |
| 2024-02-22 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 1,254 | 8.71 | 10.9K | 311,733 | — | ↗ |
| 2024-02-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 37,196 | 8.92 | 331.8K | 1,558,769 | — | ↗ |
| 2024-02-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 17,036 | 8.92 | 152.0K | 238,636 | — | ↗ |
| 2024-02-20 | Miller Aine | Officer | F-InKind | D | Ordinary Shares | 11,782 | 8.92 | 105.1K | 133,534 | — | ↗ |
| 2024-02-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 17,595 | 8.92 | 156.9K | 260,684 | — | ↗ |
| 2024-02-20 | GRAHAM RICHARD A | Officer | F-InKind | D | Ordinary Shares | 19,294 | 8.92 | 172.1K | 314,915 | — | ↗ |
| 2024-02-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 18,219 | 8.92 | 162.5K | 312,987 | — | ↗ |
| 2024-02-06 | Miller Aine | Officer | — | D | Ordinary Shares | 0 | 0.00 | — | 145,316 | — | ↗ |
| 2023-12-21 | Grant Jeremy T | Director | A-Award | A | Ordinary Shares | 8,826 | 0.00 | — | 8,826 | — | ↗ |
| 2023-11-21 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 1,378 | 10.29 | 14.2K | 331,206 | — | ↗ |
| 2023-11-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,804 | 10.37 | 163.9K | 1,595,965 | — | ↗ |
| 2023-11-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 6,187 | 10.37 | 64.2K | 255,672 | — | ↗ |
| 2023-11-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 7,363 | 10.37 | 76.4K | 278,279 | — | ↗ |
| 2023-11-20 | GRAHAM RICHARD A | Officer | F-InKind | D | Ordinary Shares | 12,630 | 10.37 | 131.0K | 334,209 | — | ↗ |
| 2023-11-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 7,982 | 10.37 | 82.8K | 332,584 | — | ↗ |
| 2023-11-14 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,482 | 10.22 | 25.4K | 346,839 | — | ↗ |
| 2023-10-30 | GRAHAM RICHARD A | Officer | A-Award | A | Ordinary Shares | 15,000 | 0.00 | — | 349,321 | — | ↗ |
| 2023-10-16 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,482 | 9.03 | 22.4K | 334,321 | — | ↗ |
| 2023-09-14 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,482 | 9.89 | 24.5K | 336,803 | — | ↗ |
| 2023-08-22 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 1,807 | 9.47 | 17.1K | 340,566 | — | ↗ |
| 2023-08-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,804 | 9.70 | 153.3K | 1,611,769 | — | ↗ |
| 2023-08-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 7,114 | 9.70 | 69.0K | 261,859 | — | ↗ |
| 2023-08-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 8,912 | 9.70 | 86.4K | 285,297 | — | ↗ |
| 2023-08-20 | GRAHAM RICHARD A | Officer | F-InKind | D | Ordinary Shares | 10,461 | 9.70 | 101.5K | 339,285 | — | ↗ |
| 2023-08-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 10,460 | 9.70 | 101.5K | 342,373 | — | ↗ |
| 2023-08-11 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,322 | 9.99 | 23.2K | 349,746 | — | ↗ |
| 2023-07-14 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,322 | 9.84 | 22.8K | 352,068 | — | ↗ |
| 2023-06-14 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,322 | 10.69 | 24.8K | 354,390 | — | ↗ |
| 2023-06-08 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 1,790 | 11.13 | 19.9K | 352,833 | — | ↗ |
| 2023-05-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,804 | 11.21 | 177.2K | 1,627,573 | — | ↗ |
| 2023-05-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 8,744 | 11.21 | 98.0K | 268,973 | — | ↗ |
| 2023-05-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 11,469 | 11.21 | 128.6K | 294,209 | — | ↗ |
| 2023-05-20 | GRAHAM RICHARD A | Officer | F-InKind | D | Ordinary Shares | 10,460 | 11.21 | 117.3K | 356,712 | — | ↗ |
| 2023-05-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 5,567 | 11.21 | 62.4K | 354,623 | — | ↗ |
| 2023-05-15 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,322 | 11.26 | 26.1K | 367,172 | — | ↗ |
| 2023-05-02 | Smaldone Alsup Laurie | Director | A-Award | A | Ordinary Shares | 9,132 | 0.00 | — | 53,794 | — | ↗ |
| 2023-05-02 | PAKIANATHAN DEEPIKA | Director | A-Award | A | Share Option (Right to Buy) | 22,044 | 10.95 | 241.4K | 22,044 | — | ↗ |
| 2023-05-02 | O'Connor Donal | Director | A-Award | A | Share Option (Right to Buy) | 22,044 | 10.95 | 241.4K | 22,044 | — | ↗ |
| 2023-05-02 | MITCHELL DEAN J | Director | A-Award | A | Share Option (Right to Buy) | 22,044 | 10.95 | 241.4K | 22,044 | — | ↗ |
| 2023-05-02 | MALKIEL BURTON G | Director | A-Award | A | Share Option (Right to Buy) | 22,044 | 10.95 | 241.4K | 22,044 | — | ↗ |
| 2023-05-02 | GRAY SUSANNAH | Director | A-Award | A | Ordinary Shares | 9,132 | 0.00 | — | 20,951 | — | ↗ |
| 2023-05-02 | BROSHY ERAN | Director | A-Award | A | Share Option (Right to Buy) | 22,044 | 10.95 | 241.4K | 22,044 | — | ↗ |
| 2023-04-14 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,323 | 11.88 | 27.6K | 369,494 | — | ↗ |
| 2023-04-11 | Kelly James Connor | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-03-14 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,323 | 10.32 | 24.0K | 371,817 | — | ↗ |
| 2023-03-09 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 4,000 | 10.20 | 40.8K | 360,190 | — | ↗ |
| 2023-03-06 | GRAHAM RICHARD A | Officer | S-Sale | D | Ordinary Shares | 2,323 | 10.05 | 23.3K | 374,140 | — | ↗ |
| 2023-03-01 | Winningham Rick E | Director / Officer | A-Award | A | Ordinary Shares | 330,000 | 0.00 | — | 1,643,377 | — | ↗ |
| 2023-03-01 | Sawaf Aziz | Officer | A-Award | A | Ordinary Shares | 80,000 | 0.00 | — | 277,717 | — | ↗ |
| 2023-03-01 | Grimaud Brett A. | Officer | A-Award | A | Ordinary Shares | 75,000 | 0.00 | — | 304,958 | — | ↗ |
| 2023-03-01 | GRAHAM RICHARD A | Officer | A-Award | A | Ordinary Shares | 75,000 | 0.00 | — | 376,463 | — | ↗ |
| 2023-03-01 | Farnum Rhonda | Officer | A-Award | A | Ordinary Shares | 75,000 | 0.00 | — | 364,190 | — | ↗ |
| 2023-02-26 | GRAY SUSANNAH | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-02-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 37,420 | 10.44 | 390.7K | 1,313,377 | — | ↗ |
| 2023-02-20 | Sawaf Aziz | Officer | F-InKind | D | Ordinary Shares | 6,783 | 10.44 | 70.8K | 197,717 | — | ↗ |
| 2023-02-20 | Grimaud Brett A. | Officer | F-InKind | D | Ordinary Shares | 10,198 | 10.44 | 106.5K | 229,958 | — | ↗ |
| 2023-02-20 | GRAHAM RICHARD A | Officer | F-InKind | D | Ordinary Shares | 12,057 | 10.44 | 125.9K | 301,463 | — | ↗ |
| 2023-02-20 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 7,119 | 10.44 | 74.3K | 289,190 | — | ↗ |
| 2023-02-14 | Grimaud Brett A. | Officer | — | D | Ordinary Shares | 0 | 0.00 | — | 240,156 | — | ↗ |
| 2023-01-01 | Sawaf Aziz | Director / Officer | — | D | Ordinary Shares | 0 | 0.00 | — | 204,500 | — | ↗ |
| 2022-12-14 | Winningham Rick E | Director / Officer | S-Sale | D | Ordinary Shares | 50,000 | 11.19 | 559.5K | 1,350,797 | — | ↗ |
| 2022-12-13 | Winningham Rick E | Director / Officer | G-Gift | D | Ordinary Shares | 9,000 | 0.00 | — | 1,400,797 | — | ↗ |
| 2022-12-01 | GRAHAM RICHARD A | Director | S-Sale | D | Ordinary Shares | 2,084 | 10.73 | 22.4K | 313,520 | — | ↗ |
| 2022-11-22 | O'Connor Donal | Director | D-Return | D | Ordinary Shares | 10,000 | 10.50 | 105.0K | 43,886 | — | ↗ |
| 2022-11-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,804 | 10.85 | 171.5K | 1,409,797 | — | ↗ |
| 2022-11-20 | GRAHAM RICHARD A | Director | F-InKind | D | Ordinary Shares | 27,350 | 10.85 | 296.7K | 315,604 | — | ↗ |
| 2022-11-20 | Farnum Rhonda | Director | F-InKind | D | Ordinary Shares | 23,268 | 10.85 | 252.5K | 296,309 | — | ↗ |
| 2022-11-16 | GRAHAM RICHARD A | Director | F-InKind | D | Ordinary Shares | 2,800 | 11.20 | 31.4K | 342,954 | — | ↗ |
| 2022-09-20 | Samaha Eli | Director | — | I | COM | 0 | 0.00 | — | 7,012,226 | — | ↗ |
| 2022-09-19 | Weiss Asset Management LP | 10% Owner | — | I | Ordinary shares | 0 | 0.00 | — | 7,457,060 | — | ↗ |
| 2022-08-19 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 15,804 | 9.34 | 147.6K | 1,424,784 | — | ↗ |
| 2022-08-19 | Hindman Andrew A. | Director / Officer | F-InKind | D | Ordinary Shares | 25,676 | 9.34 | 239.8K | 473,507 | — | ↗ |
| 2022-08-19 | GRAHAM RICHARD A | Director | F-InKind | D | Ordinary Shares | 18,991 | 9.34 | 177.4K | 345,754 | — | ↗ |
| 2022-08-19 | Farnum Rhonda | Director | F-InKind | D | Ordinary Shares | 10,413 | 9.34 | 97.3K | 319,577 | — | ↗ |
| 2022-08-16 | GRAHAM RICHARD A | Director | S-Sale | D | Ordinary Shares | 4,906 | 9.71 | 47.6K | 364,745 | — | ↗ |
| 2022-08-09 | GRAHAM RICHARD A | Director | S-Sale | D | Ordinary Shares | 15,086 | 8.79 | 132.6K | 369,651 | — | ↗ |
| 2022-07-25 | Hindman Andrew A. | Director / Officer | A-Award | A | Ordinary Shares | 20,000 | 0.00 | — | 499,183 | — | ↗ |
| 2022-05-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 11,025 | 8.74 | 96.4K | 1,440,588 | — | ↗ |
| 2022-05-20 | Hindman Andrew A. | Director / Officer | F-InKind | D | Ordinary Shares | 3,365 | 8.74 | 29.4K | 479,183 | — | ↗ |
| 2022-05-20 | GRAHAM RICHARD A | Director | F-InKind | D | Ordinary Shares | 3,947 | 8.74 | 34.5K | 384,737 | — | ↗ |
| 2022-05-20 | Farnum Rhonda | Director | S-Sale | D | Ordinary Shares | 1,081 | 8.93 | 9.7K | 329,990 | — | ↗ |
| 2022-04-26 | YOUNG WILLIAM D | Director | A-Award | A | Ordinary Shares | 9,852 | 0.00 | — | 78,010 | — | ↗ |
| 2022-04-26 | Smaldone Alsup Laurie | Director | A-Award | A | Ordinary Shares | 9,852 | 0.00 | — | 44,662 | — | ↗ |
| 2022-04-26 | PAKIANATHAN DEEPIKA | Director | A-Award | A | Ordinary Shares | 9,852 | 0.00 | — | 27,747 | — | ↗ |
| 2022-04-26 | O'Connor Donal | Director | A-Award | A | Share Option (Right to Buy) | 28,000 | 10.15 | 284.2K | 28,000 | — | ↗ |
| 2022-04-26 | MITCHELL DEAN J | Director | A-Award | A | Ordinary Shares | 9,852 | 0.00 | — | 60,886 | — | ↗ |
| 2022-04-26 | MALKIEL BURTON G | Director | A-Award | A | Share Option (Right to Buy) | 28,000 | 0.00 | — | 28,000 | — | ↗ |
| 2022-04-26 | BROSHY ERAN | Director | A-Award | A | Ordinary Shares | 9,852 | 0.00 | — | 60,886 | — | ↗ |
| 2022-02-28 | Farnum Rhonda | Officer | S-Sale | D | Ordinary Shares | 2,356 | 10.16 | 23.9K | 333,271 | — | ↗ |
| 2022-02-25 | Winningham Rick E | Director / Officer | A-Award | A | Ordinary Shares | 170,000 | 0.00 | — | 1,449,300 | — | ↗ |
| 2022-02-18 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 22,710 | 9.61 | 218.2K | 1,279,300 | — | ↗ |
| 2022-02-18 | PITZER KENNETH R | Officer | F-InKind | D | Ordinary Shares | 27,299 | 9.61 | 262.3K | 380,123 | — | ↗ |
| 2022-02-18 | Hindman Andrew A. | Officer | F-InKind | D | Ordinary Shares | 25,973 | 9.61 | 249.6K | 481,285 | — | ↗ |
| 2022-02-18 | GRAHAM RICHARD A | Officer | F-InKind | D | Ordinary Shares | 20,377 | 9.61 | 195.8K | 388,684 | — | ↗ |
| 2022-02-18 | Farnum Rhonda | Officer | F-InKind | D | Ordinary Shares | 11,824 | 9.61 | 113.6K | 335,627 | — | ↗ |
| 2022-02-18 | BRADY ANN | Officer | F-InKind | D | Ordinary Shares | 8,369 | 9.61 | 80.4K | 110,319 | — | ↗ |
| 2022-02-07 | PITZER KENNETH R | Officer | A-Award | A | Ordinary Shares | 52,000 | 0.00 | — | 407,422 | — | ↗ |
| 2021-12-14 | Farnum Rhonda | Officer | A-Award | A | Ordinary Shares | 27,500 | 0.00 | — | 347,451 | — | ↗ |
| 2021-12-02 | Hindman Andrew A. | Officer | A-Award | A | Ordinary Shares | 340,000 | 0.00 | — | 507,258 | — | ↗ |
| 2021-12-02 | GRAHAM RICHARD A | Officer | A-Award | A | Ordinary Shares | 240,000 | 0.00 | — | 409,061 | — | ↗ |
| 2021-12-01 | Farnum Rhonda | Officer | — | D | Ordinary Shares | 0 | 0.00 | — | 319,951 | — | ↗ |
| 2021-11-19 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 11,404 | 8.36 | 95.3K | 1,302,010 | — | ↗ |
| 2021-11-19 | WORBOYS PHILIP D | Officer | F-InKind | D | Ordinary Shares | 4,310 | 8.36 | 36.0K | 330,752 | — | ↗ |
| 2021-11-19 | SABESAN VIJAY | Officer | F-InKind | D | Ordinary Shares | 5,191 | 8.36 | 43.4K | 235,524 | — | ↗ |
| 2021-11-19 | PITZER KENNETH R | Officer | F-InKind | D | Ordinary Shares | 4,310 | 8.36 | 36.0K | 355,422 | — | ↗ |
| 2021-11-19 | PASQUALONE FRANK | Officer | F-InKind | D | Ordinary Shares | 3,779 | 8.36 | 31.6K | 429,783 | — | ↗ |
| 2021-11-19 | Hindman Andrew A. | Officer | F-InKind | D | Ordinary Shares | 1,350 | 8.36 | 11.3K | 167,258 | — | ↗ |
| 2021-11-19 | GRAHAM RICHARD A | Officer | F-InKind | D | Ordinary Shares | 4,263 | 8.36 | 35.6K | 0 | — | ↗ |
| 2021-11-19 | BRADY ANN | Officer | F-InKind | D | Ordinary Shares | 3,169 | 8.36 | 26.5K | 118,688 | — | ↗ |
| 2021-08-20 | Winningham Rick E | Director / Officer | F-InKind | D | Ordinary Shares | 11,404 | 14.05 | 160.2K | 1,313,414 | — | ↗ |
| 2021-08-20 | WORBOYS PHILIP D | Officer | F-InKind | D | Ordinary Shares | 4,307 | 14.05 | 60.5K | 335,062 | — | ↗ |
| 2021-08-20 | Shafer Bradford J | Officer | F-InKind | D | Ordinary Shares | 4,307 | 14.05 | 60.5K | 277,831 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-147.2K
Shares Outstanding
51.55M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Rick E Winningham Chief Executive Officer | 1.05M | — | — | — | 419.2K | 5.4K | 1.47M | 0.00% | ↗ |
| 2 | 2025 | Aine Miller Senior Vice President, Development and Head of Ireland Office | 506.2K | — | 701.3K | — | 170.0K | 71.1K | 1.45M | 48.41% | ↗ |
| 3 | 2025 | Rhonda F. Farnum Chief Business Officer and Senior Vice President, Commercial & Medical Affairs | 506.3K | — | 701.3K | — | 169.3K | 7.4K | 1.38M | 50.66% | ↗ |
| 4 | 2024 | Rick E Winningham Chief Executive Officer | 1.05M | 9.8K | 2.44M | — | 490.2K | 5.0K | 4.00M | 61.15% | ↗ |
| 5 | 2024 | Brett A. Grimaud Senior Vice President, General Counsel & Secretary | 480.9K | — | 790.6K | — | 205.0K | 5.0K | 1.48M | 53.37% | ↗ |
| 6 | 2024 | Aziz Sawaf Senior Vice President, Chief Financial Officer | 462.4K | — | 790.6K | — | 197.0K | 777.00 | 1.45M | 54.50% | ↗ |
| 7 | 2023 | Rick E Winningham Chief Executive Officer | 1.05M | — | 3.02M | — | 251.0K | 5.0K | 4.32M | 69.82% | ↗ |
| 8 | 2023 | Richard Graham Former Senior Vice President, Strategic Advisor R&D | 518.3K | — | 753.0K | — | 130.0K | 5.0K | 1.41M | 53.54% | ↗ |
| 9 | 2023 | Aziz Sawaf Senior Vice President, Chief Financial Officer | 448.5K | 9.0K | 803.2K | — | 126.0K | — | 1.39M | 57.92% | ↗ |
| 10 | 2022 | Rick E Winningham Chief Executive Officer | 1.05M | — | 1.74M | 2.76M | 722.7K | 5.1K | 6.27M | 71.70% | ↗ |
| 11 | 2022 | Richard A. Graham Senior Vice President, Research and Development | 482.9K | 291.1K | — | — | 287.5K | 5.1K | 1.07M | 0.00% | ↗ |
| 12 | 2022 | Richard Graham Former Senior Vice President, Strategic Advisor R&D | 482.9K | 291.1K | — | — | 287.5K | 5.1K | 1.07M | 0.00% | ↗ |
| 13 | 2022 | Ann B. Brady Former President of Theravance Biopharma Ireland Ltd. | 68.9K | 504.9K | 169.6K | — | — | 312.8K | 1.06M | 16.06% | ↗ |
| 14 | 2022 | Andrew A. Hindman Former Senior Vice President and Chief Financial Officer | 572.0K | 357.5K | — | — | — | 60.1K | 989.6K | 0.00% | ↗ |
| 15 | 2022 | Rhonda F. Farnum Chief Business Officer and Senior Vice President, Commercial and Medical Affairs | 460.0K | 213.2K | — | — | 264.5K | 5.1K | 942.8K | 0.00% | ↗ |
| 16 | 2021 | Andrew A. Hindman Former Senior Vice President and Chief Financial Officer | 570.4K | — | 3.93M | — | — | 5.0K | 4.51M | 87.23% | ↗ |
| 17 | 2021 | Andrew A. Hindman Senior Vice President and Chief Financial Officer | 570.4K | — | 3.93M | — | — | 5.0K | 4.51M | 87.23% | ↗ |
| 18 | 2021 | Rick E Winningham Chief Executive Officer | 1.04M | — | 3.40M | — | — | 7.1K | 4.45M | 76.37% | ↗ |
| 19 | 2021 | Richard A. Graham Senior Vice President, Research and Development | 464.4K | — | 3.27M | — | — | 5.0K | 3.74M | 87.43% | ↗ |
| 20 | 2021 | Rhonda F. Farnum Chief Business Officer and Senior Vice President, Commercial and Medical Affairs | 430.5K | — | 2.59M | — | — | 5.0K | 3.02M | 85.59% | ↗ |
| 21 | 2021 | Philip D. Worboys Former Senior Vice President, Research and Translational Science | 489.5K | — | 1.51M | — | — | 194.6K | 2.20M | 68.86% | ↗ |
| 22 | 2021 | Frank Pasqualone Former Senior Vice President and Chief Business Officer | 505.9K | — | 1.30M | — | — | 51.8K | 1.86M | 69.98% | ↗ |
| 23 | 2021 | Kenneth R. Pitzer Senior Vice President, Product Strategy and Commercial Planning | 424.3K | — | 1.30M | — | — | 5.0K | 1.73M | 75.17% | ↗ |
| 24 | 2020 | Rick E Winningham Chief Executive Officer | 1.01M | — | 4.98M | — | 579.6K | 6.0K | 6.58M | 75.67% | ↗ |
| 25 | 2020 | Vijay Sabesan Senior Vice President, Technical Operations | 407.7K | — | 1.90M | — | 760.3K | 6.5K | 3.08M | 61.84% | ↗ |
| 26 | 2020 | Brett Haumann Senior Vice President, Clinical Development and Chief Medical Officer | 572.6K | — | 1.90M | — | 213.6K | 53.3K | 2.74M | 69.39% | ↗ |
| 27 | 2020 | Bradford J. Shafer Executive Vice President, General Counsel and Secretary | 556.3K | — | 1.90M | — | 265.0K | 6.0K | 2.73M | 69.70% | ↗ |
| 28 | 2020 | Frank Pasqualone Former Senior Vice President and Chief Business Officer | 535.9K | — | 1.90M | — | 249.8K | 6.0K | 2.69M | 70.62% | ↗ |
| 29 | 2020 | Andrew A. Hindman Former Senior Vice President and Chief Financial Officer | 551.6K | — | 1.28M | — | 265.3K | 5.9K | 2.10M | 60.78% | ↗ |
| 30 | 2020 | Andrew A. Hindman Senior Vice President and Chief Financial Officer | 551.6K | — | 1.28M | — | 265.3K | 5.9K | 2.10M | 60.78% | ↗ |
| 31 | 2019 | Rick E Winningham Chief Executive Officer | 983.7K | — | 4.47M | — | 473.9K | 5.5K | 5.93M | 75.34% | ↗ |
| 32 | 2019 | Andrew A. Hindman Senior Vice President and Chief Financial Officer | 315.0K | 175.0K | 847.0K | 2.20M | 216.0K | — | 3.76M | 81.21% | ↗ |
| 33 | 2019 | Bradford J. Shafer Executive Vice President, General Counsel and Secretary | 537.4K | — | 1.71M | — | 215.6K | 7.0K | 2.47M | 69.22% | ↗ |
| 34 | 2019 | Brett Haumann Senior Vice President, Clinical Development and Chief Medical Officer | 543.0K | — | 1.71M | — | 170.0K | 42.4K | 2.46M | 69.34% | ↗ |
| 35 | 2019 | Frank Pasqualone Senior Vice President and Chief Commercial Operations Officer | 520.3K | 16.4K | 1.71M | — | 208.6K | 7.1K | 2.46M | 69.43% | ↗ |
| 36 | 2019 | Frank Pasqualone Former Senior Vice President and Chief Business Officer | 520.3K | 16.4K | 1.71M | — | 225.0K | 7.1K | 2.46M | 69.43% | ↗ |
| 37 | 2019 | Renee D. Gala Former Senior Vice President and Chief Financial Officer, Treasurer | 3.6K | — | — | — | — | 6.1K | 9.7K | 0.00% | ↗ |
| 38 | 2018 | Shehnaaz Suliman Former Senior Vice President, Corporate Development and Strategy | 483.8K | 31.5K | 1.85M | — | 290.8K | 5.0K | 2.66M | 69.50% | ↗ |
| 39 | 2018 | Rick E Winningham Chief Executive Officer | 956.6K | 74.8K | 796.3K | — | 690.2K | 5.0K | 2.52M | 31.56% | ↗ |
| 40 | 2018 | Brett Haumann Senior Vice President, Clinical Development and Chief Medical Officer | 497.8K | 34.1K | 256.0K | — | 315.0K | 414.3K | 1.52M | 16.87% | ↗ |
| 41 | 2018 | Bradford J. Shafer Executive Vice President, General Counsel and Secretary | 518.1K | 33.8K | 256.0K | — | 311.7K | 5.0K | 1.12M | 22.76% | ↗ |
| 42 | 2018 | Frank Pasqualone Senior Vice President and Chief Commercial Operations Officer | 506.4K | 32.9K | 256.0K | — | 303.8K | 6.0K | 1.11M | 23.16% | ↗ |
| 43 | 2018 | Renee D. Gala Former Senior Vice President and Chief Financial Officer, Treasurer | 473.1K | 30.9K | 256.0K | — | 285.4K | 5.0K | 1.05M | 24.37% | ↗ |
| 44 | 2017 | Shehnaaz Suliman Former Senior Vice President, Corporate Development and Strategy | 201.5K | 245.0K | 638.6K | 2.84M | 142.5K | 3.0K | 4.08M | 85.47% | ↗ |
| 45 | 2017 | Shehnaaz Suliman Senior Vice President, Corporate Development and Strategy | 201.5K | 245.0K | 638.6K | 2.84M | 142.5K | 3.0K | 4.08M | 85.47% | ↗ |
| 46 | 2017 | Rick E Winningham Chief Executive Officer | 932.5K | 202.0K | 874.7K | — | 303.0K | 5.0K | 2.32M | 37.75% | ↗ |
| 47 | 2017 | Bradford J. Shafer Executive Vice President, General Counsel and Secretary | 500.6K | 90.4K | 281.2K | — | 135.5K | 5.0K | 1.01M | 27.77% | ↗ |
| 48 | 2017 | Renee D. Gala SVP and Chief Financial Officer, Treasurer | 443.3K | 80.0K | 281.2K | — | 120.0K | 5.0K | 929.5K | 30.25% | ↗ |
| 49 | 2017 | Renee D. Gala Former Senior Vice President and Chief Financial Officer, Treasurer | 443.3K | 80.0K | 281.2K | — | 120.0K | 5.0K | 929.5K | 30.25% | ↗ |
| 50 | 2017 | Frank Pasqualone Senior Vice President and Global Head, Acute Care Business | 505.1K | 45.6K | 281.2K | — | 68.4K | 6.0K | 906.3K | 31.02% | ↗ |
| 51 | 2017 | Frank Pasqualone Senior Vice President and Chief Commercial Operations Officer | 505.1K | 45.6K | 281.2K | — | 68.4K | 6.0K | 906.3K | 31.02% | ↗ |
| 52 | 2016 | Rick E Winningham Chief Executive Officer | 903.5K | 189.7K | 4.75M | — | 433.7K | 5.0K | 6.28M | 75.61% | ↗ |
| 53 | 2016 | Bradford J. Shafer Executive Vice President, General Counsel and Secretary | 478.4K | 87.5K | 1.95M | — | 191.4K | 5.0K | 2.71M | 71.90% | ↗ |
| 54 | 2016 | Philip D. Worboys Senior Vice President, Translational Science | 393.8K | 63.0K | 1.78M | — | 157.0K | 5.0K | 2.40M | 74.21% | ↗ |
| 55 | 2016 | Sharathchandra (Sharath) S. Hegde Senior Vice President, Research | 392.5K | 63.0K | 1.78M | — | 157.0K | 5.0K | 2.40M | 74.25% | ↗ |
| 56 | 2016 | Frank Pasqualone Senior Vice President and Global Head, Acute Care Business | 491.6K | 12.3K | 1.53M | — | 196.7K | 5.1K | 2.23M | 68.39% | ↗ |
| 57 | 2016 | Renee D. Gala SVP and Chief Financial Officer, Treasurer | 429.5K | 75.2K | 1.53M | — | 171.8K | 5.0K | 2.21M | 69.13% | ↗ |
| 58 | 2016 | Renee D. Gala Former Senior Vice President and Chief Financial Officer, Treasurer | 429.5K | 75.2K | 1.53M | — | 171.8K | 5.0K | 2.21M | 69.13% | ↗ |
| 59 | 2015 | Rick E Winningham Chief Executive Officer | 902.1K | — | 4.33M | — | 271.1K | 814.00 | 5.50M | 78.65% | ↗ |
| 60 | 2015 | Renee D. Gala SVP and Chief Financial Officer, Treasurer | 428.3K | — | 2.34M | — | 161.1K | 814.00 | 2.93M | 79.83% | ↗ |
| 61 | 2015 | Frank Pasqualone SVP, Operations | 490.2K | — | 2.25M | — | 184.4K | 719.00 | 2.92M | 76.91% | ↗ |
| 62 | 2015 | Frank Pasqualone Senior Vice President and Global Head, Acute Care Business | 490.2K | — | 2.25M | — | 184.4K | 719.00 | 2.92M | 76.91% | ↗ |
| 63 | 2015 | Bradford J. Shafer Executive Vice President, General Counsel and Secretary | 441.0K | — | 2.08M | — | 165.9K | 814.00 | 2.68M | 77.36% | ↗ |
| 64 | 2014 | Rick E Winningham Chief Executive Officer | 738.7K | 627.5K | 6.60M | 6.93M | — | 500.00 | 14.90M | 90.83% | ↗ |
| 65 | 2014 | Rick E Winningham Chief Executive Officer | 738.7K | 627.5K | — | 6.93M | — | 500.00 | 14.90M | 46.54% | ↗ |
| 66 | 2014 | Bradford J. Shafer SVP, General Counsel | 319.5K | 240.4K | — | 3.10M | — | 500.00 | 6.66M | 46.55% | ↗ |
| 67 | 2014 | Bradford J. Shafer Executive Vice President, General Counsel and Secretary | 319.5K | 240.4K | 3.00M | 3.10M | — | 500.00 | 6.66M | 91.59% | ↗ |
| 68 | 2014 | Frank Pasqualone SVP, Operations | 460.6K | 286.3K | 764.8K | 4.74M | — | 500.00 | 6.25M | 88.04% | ↗ |
| 69 | 2013 | Rick E Winningham Chief Executive Officer | 857.9K | 129.0K | — | — | 516.0K | 500.00 | 1.75M | 0.00% | ↗ |
| 70 | 2013 | Bradford J. Shafer SVP, General Counsel | 413.8K | 52.9K | — | — | 207.4K | 500.00 | 785.7K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Rick E. Winningham | Chief Executive Officer & Director | 1M | male |
| Aine Miller | Senior Vice President of Development & Head of Ireland Office | 747.3K | — |
| Brett A. Grimaud | Senior Vice President, General Counsel & Secretary | 690.9K | male |
| Rhonda F. Farnum | Chief Business Officer and Senior Vice President of Commercial & Medical Affairs | 682.9K | female |
| Aziz Sawaf | Senior Vice President & Chief Financial Officer | 660.2K | male |
| Stacy L. Pryce | Senior Vice President & Chief Strategy Officer | — | female |
| Stuart Knight | Senior Vice President of IT&I and Chief Information Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-03-24 | 2025-04-23 | George Whitesides | CA27 | — | Sale (Full) | $15,001 - $50,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TBPH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
